Form 8-K - Current report:
SEC Accession No. 0001493152-26-036109
Filing Date
2026-08-05
Accepted
2026-08-05 08:30:20
Documents
12
Period of Report
2026-08-05
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 41854
  Complete submission text file 0001493152-26-036109.txt   252997

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE drma-20260805.xsd EX-101.SCH 3780
3 XBRL DEFINITION FILE drma-20260805_def.xml EX-101.DEF 26634
4 XBRL LABEL FILE drma-20260805_lab.xml EX-101.LAB 36717
5 XBRL PRESENTATION FILE drma-20260805_pre.xml EX-101.PRE 25258
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5369
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40739 | Film No.: 261241452
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)